Pali D. Shah
Rank 26 by 10-year citations to CLAD papers (55 papers, 689 citations). Role unknown; field: respiratory medicine.
As of . Primary source: ORCID record.
Summary
Pali D. Shah. Role: unknown. No source read in this review states the role of this author. Field indicated by the unit name: respiratory medicine, critical care (source: affiliation lines on the author's own papers, for example https://doi.org/10.1111/tid.70206 (2026): "Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine Baltimore Maryland USA"; also on https://doi.org/10.1183/13993003.00182-2025, https://doi.org/10.1183/13993003.02). Affiliation: unknown (marked missing). Basis: unverified; OpenAlex lists "Johns Hopkins University" on the most recent corpus paper (2026). Not confirmed as current.. Counts in the OpenAlex corpus (retrieved 2026-10-10): 55 papers and 689 citations over ten years; 0 first-author and 5 last-author papers. Ranks: main 26, excluding consensus papers 15, first or last author 87. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.
Citation ranks (10 years)
| Main rank | Rank excluding consensus papers | Rank by first or last author papers |
|---|---|---|
| 26 of 800 | 15 of 794 | 87 of 512 |
Citations: 689 in total, 689 excluding consensus and guideline papers (0 of this author's papers excluded), 90 on first or last author papers (0 first, 5 last).
Ranking method: see the methodology note at the top of the People list and the full methodology document.
Role and field
- Role
- unknown
- Role status
- unknown (no source read in this review states the role)
- Field
- respiratory medicine, critical care
- Field basis
- affiliation lines on the author's own papers, for example https://doi.org/10.1111/tid.70206 (2026): "Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine Baltimore Maryland USA"; also on https://doi.org/10.1183/13993003.00182-2025, https://doi.org/10.1183/13993003.02
Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.
Details
- papers 10y
- 55
- fractional papers 10y
- 3.47
- citations 10y
- 689
- fractional citations 10y
- 38.8
- ranking retrieved
- 2026-10-10
- orcid
- 0000-0001-6021-1027
- openalex author id
- A5110287415
- merged open alex profiles
- 4
- affiliation basis
- unverified; OpenAlex lists "Johns Hopkins University" on the most recent corpus paper (2026). Not confirmed as current.
- papers excluding consensus 10y
- 55
- citations excluding consensus 10y
- 689
- consensus papers excluded 10y
- 0
- first author papers 10y
- 0
- last author papers 10y
- 5
- lead author citations 10y
- 90
- lead author papers 10y
- 5
Sources and links
- ORCID record (primary)
- OpenAlex author profile (ranking source)
- Most-cited CLAD paper in corpus: Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD) (The Journal of Heart and Lung Transplantation, 2021); 55 citations; DOI 10.1016/j.healun.2021.02.008
- Most-cited CLAD paper in corpus: Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction (American Journal of Transplantation, 2022); 30 citations; DOI 10.1111/ajt.17108
- Most-cited CLAD paper in corpus: Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death (American Journal of Transplantation, 2023); 27 citations; DOI 10.1016/j.ajt.2022.12.019
- Most-cited CLAD paper in corpus: Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study (American Journal of Respiratory and Critical Care Medicine, 2025); 24 citations; DOI 10.1164/rccm.202403-0568oc
- Most-cited CLAD paper in corpus: Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year (The Journal of Heart and Lung Transplantation, 2023); 21 citations; DOI 10.1016/j.healun.2023.02.005
- Own paper naming the unit (affiliation line)
- Own paper naming the unit (affiliation line)
Related
Links from this record
Known gaps in this record
- role or job title
- centre membership relation (not asserted)
- funding and conflicts of interest
- verified current affiliation
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.